Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02994654 · ClinicalTrials.gov registry record · NA
CONTINUED ACCESS PROTOCOL: Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries
A NA study, sponsored by Avita Medical.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT02994654 is a NA study that has completed, run by Avita Medical. The registered enrollment target is 12 participants.
The verdict
NCT02994654, a NA study, has completed, sponsored by Avita Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The overall purpose of this is study to provide continued access to the ReCell device following completion of protocol CTP001-6, and allow for collection of supplementary clinical outcome data for the ReCell device when used as an adjunct to meshed grafts in subjects with acute thermal burn injuries who require skin grafting for closure of burn injuries.
Interventions
- DEVICE ReCell
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2016-10 |
| Est. Completion | 2018-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02994654
The ClinicalTrials.gov registry entry for NCT02994654 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Avita Medical, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ReCell is the first listed.
NCT02994654 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02994654 about?
NCT02994654 is a clinical study titled "CONTINUED ACCESS PROTOCOL: Demonstration of the Safety and Effectiveness of ReCell® Combined With Meshed Skin Graft for Reduction of Donor Area in the Treatment of Acute Burn Injuries". The overall purpose of this is study to provide continued access to the ReCell device following completion of protocol CTP001-6, and allow for collection of supplementary clinical outcome data for the ReCell device when used as an adjunct to meshed grafts in subjects with acute thermal burn injuries...
What is the current status of trial NCT02994654?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2016-10. Estimated completion is 2018-09.
What interventions are being tested in trial NCT02994654?
The interventions under investigation include: ReCell (DEVICE).
Who is sponsoring clinical trial NCT02994654?
This trial is sponsored by Avita Medical, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.